COVID-19 vaccine update: DGCI panel gives nod to phase 3 trials of Bharat Biotech's Covaxin

The recommendation was given by the panel after assessing the data of phase 1 and 2 clinical trials as well as animal challenge study.

from Latest News https://ift.tt/35owFqJ